D.A. Davidson & CO. Sells 21,529 Shares of Nutrien Ltd. $NTR

Key Points

• D.A. Davidson & CO. trimmed its stake in Nutrien by 14.1%, selling 21,529 shares and leaving 130,653 shares valued at about $8.06 million at quarter-end.
• Multiple analysts have raised targets (e.g., JPMorgan to $78, TD to $81, BofA to $81), but the consensus rating remains Hold with an average target of $80.06.
• Nutrien's latest quarter missed estimates (EPS $0.83 vs. $0.87, revenue $5.12B vs. $5.26B, revenue +5.1% YoY) and the company pays a quarterly dividend of $0.55 (annualized $2.20, ~3.0% yield).

D.A. Davidson & CO. trimmed its holdings in shares of Nutrien Ltd. (NYSE:NTR - Free Report) by 14.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 130,653 shares of the company's stock after selling 21,529 shares during the period. D.A. Davidson & CO.'s holdings in Nutrien were worth $8,064,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the business. Smith Moore & CO. raised its stake in shares of Nutrien by 2.2% during the 3rd quarter. Smith Moore & CO. now owns 7,642 shares of the company's stock worth $449,000 after purchasing an additional 168 shares during the period. AMG National Trust Bank raised its stake in shares of Nutrien by 4.0% during the 3rd quarter. AMG National Trust Bank now owns 4,986 shares of the company's stock worth $293,000 after purchasing an additional 193 shares during the period. Bessemer Group Inc. raised its stake in shares of Nutrien by 27.7% during the 3rd quarter. Bessemer Group Inc. now owns 937 shares of the company's stock worth $55,000 after purchasing an additional 203 shares during the period. Farther Finance Advisors LLC raised its stake in shares of Nutrien by 11.5% during the 4th quarter. Farther Finance Advisors LLC now owns 2,103 shares of the company's stock worth $130,000 after purchasing an additional 217 shares during the period. Finally, Geneos Wealth Management Inc. raised its stake in shares of Nutrien by 42.4% during the 2nd quarter. Geneos Wealth Management Inc. now owns 735 shares of the company's stock worth $43,000 after purchasing an additional 219 shares during the period. 63.10% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on the company. JPMorgan Chase & Co. lifted their target price on Nutrien from $68.00 to $78.00 and gave the stock an "overweight" rating in a research note on Friday, February 20th. TD Securities boosted their price objective on Nutrien from $80.00 to $81.00 and gave the company a "buy" rating in a research note on Tuesday, February 17th. Bank of America boosted their price objective on Nutrien from $75.00 to $81.00 and gave the company a "neutral" rating in a research note on Wednesday, March 18th. Raymond James Financial boosted their price objective on Nutrien from $68.00 to $74.00 and gave the company a "market perform" rating in a research note on Friday, February 20th. Finally, Barclays boosted their price objective on Nutrien from $70.00 to $80.00 and gave the company an "equal weight" rating in a research note on Tuesday, March 3rd. Ten investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $80.06.

Nutrien Trading Up 0.7%

Shares of NTR opened at $72.91 on Wednesday. The business's 50-day moving average price is $74.69 and its 200-day moving average price is $66.40. Nutrien Ltd. has a twelve month low of $53.03 and a twelve month high of $85.36. The stock has a market cap of $35.05 billion, a PE ratio of 15.65 and a beta of 0.69. The company has a quick ratio of 0.70, a current ratio of 1.34 and a debt-to-equity ratio of 0.37.

Nutrien (NYSE:NTR - Get Free Report) last announced its quarterly earnings results on Wednesday, February 18th. The company reported $0.83 earnings per share for the quarter, missing the consensus estimate of $0.87 by ($0.04). Nutrien had a net margin of 8.43% and a return on equity of 8.41%. The company had revenue of $5.12 billion for the quarter, compared to the consensus estimate of $5.26 billion. During the same quarter in the prior year, the company earned $0.31 earnings per share. The company's quarterly revenue was up 5.1% on a year-over-year basis. On average, equities analysts forecast that Nutrien Ltd. will post 4.95 EPS for the current fiscal year.

Nutrien Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, April 16th. Stockholders of record on Tuesday, March 31st were given a dividend of $0.55 per share. This is a boost from Nutrien's previous quarterly dividend of $0.55. This represents a $2.20 annualized dividend and a dividend yield of 3.0%. The ex-dividend date was Tuesday, March 31st. Nutrien's dividend payout ratio (DPR) is currently 47.21%.

Nutrien Profile

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien's business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.